Displaying 1 - 5 of 10
Author:Traboulsee, Anthony Kleiter, Ingo Palace, Jacqueline Fujihara, Kazuo Saiz, Albert Vodopivec, Ivana Klingelschmitt, Gaelle Marcillat, Carole Bennett, Jeffrey
Session Name:S5: Autoimmune Neurology: NMOSD and MG, A Focus on Treatment Trials
Topic:Autoimmune Neurology
Program Number:S5.001
Author Institution:University of British Columbia, Vancouver, BC, Canada Ruhr University Bochum, Bochum, Germany John Radcliffe Hospital, Oxford, United Kingdom Fukushima Medical University School of Medicine, Fukushima, Japan University of Barcelona, Barcelona, Spain F. Hoffmann-La Roche Ltd, Basel, Switzerland University of Colorado School of Medicine, Aurora, CO
Author:Pittock, Sean Barnett, Michael Bennett, Jeffrey Berthele, Achim de Sèze, Jérôme Levy, Michael Nakashima, Ichiro Oreja Guevara, Celia Palace, Jacqueline Paul, Friedemann Pozzilli, Carlo Allen, Kerstin Mashhoon, Yasmin Yountz, Marcus Kim, Ho Jin
Session Name:S5: Autoimmune Neurology: NMOSD and MG, A Focus on Treatment Trials
Topic:Autoimmune Neurology
Program Number:S5.002
Author Institution:Department of Neurology, Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, MN, USA, Rochester, MN Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia Department of Neurology, Royal Prince Alfred Hospital, Sydney, NSW, Australia, Camperdown, Australia Departments of Neurology and Ophthalmology, Programs in Neuroscience and Immunology, University of Colorado, Aurora, CO, USA, Aurora, CO Department of Neurology, School of Medicine, Technical University of Munich, Munich, Germany, Muenchen, Germany Department of Neurology and Clinical Investigation Center, CHU de Strasbourg, Strasbourg, France, Strasbourg, France Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA, Boston, MA Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan Division of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan, Sendai, Japan Department of Neurology, Hospital Clínico Universitario San Carlos, IdISCC, Madrid, Spain Department of Medicine, Universidad Complutense de Madrid, Madrid, Spain, Madrid, Spain Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK, Oxford, United Kingdom Experimental and Clinical Research Center and NeuroCure Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité – Universitätsmedizin Berlin, Berlin, Germany, Berlin, Germany Department of Human Neuroscience, University Sapienza, Rome, Italy, Rome, Italy Alexion, AstraZeneca Rare Disease, Boston, MA, USA, Boston, MA Alexion, AstraZeneca Rare Disease, Boston, MA, USA, Watertown, MA Alexion, AstraZeneca Rare Disease, Boston, MA, USA *At the time this research was conducted., Needham, MA Department of Neurology, National Cancer Center, Goyang, South Korea, Goyang, Korea, Republic of
Author:Levy, Michael Pittock, Sean Barnett, Michael Bennett, Jeffrey Berthele, Achim De Seze, Jerome Nakashima, Ichiro Oreja Guevara, Celia Palace, Jacqueline Paul, Friedemann Pozzilli, Carlo Allen, Kerstin Mashhoon, Yasmin Yountz, Marcus Kim, Ho Jin
Session Name:S5: Autoimmune Neurology: NMOSD and MG, A Focus on Treatment Trials
Topic:Autoimmune Neurology
Program Number:S5.003
Author Institution:Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA, Boston, MA Department of Neurology, Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, MN, USA, Rochester, MN Brain and Mind Centre, University of Sydney, Sydney, NSW, Australia Department of Neurology, Royal Prince Alfred Hospital, Sydney, NSW, Australia, Camperdown, Australia Departments of Neurology and Ophthalmology, Programs in Neuroscience and Immunology, University of Colorado, Aurora, CO, USA, Aurora, CO Department of Neurology, School of Medicine, Technical University of Munich, Munich, Germany, Muenchen, Germany Department of Neurology and Clinical Investigation Center, CHU de Strasbourg, France, Strasbourg, France Department of Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan Division of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan, Sendai, Japan Department of Neurology, Hospital Clínico Universitario San Carlos, IdISCC, Madrid, Spain Department of Medicine, Universidad Complutense de Madrid, Madrid, Spain, Madrid, Spain Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK, Oxford, United Kingdom Experimental and Clinical Research Center and NeuroCure Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité – Universitätsmedizin Berlin, Berlin, Germany, Berlin, Germany Department of Human Neuroscience, University Sapienza, Rome, Italy, Rome, Italy Alexion, AstraZeneca Rare Disease, Boston, MA, USA, Boston, MA Alexion, AstraZeneca Rare Disease, Boston, MA, USA, Watertown, MA Alexion, AstraZeneca Rare Disease, Boston, MA, USA *At the time this research was conducted., Needham, MA Department of Neurology, National Cancer Center, Goyang, South Korea, Goyang, Korea, Republic of
Author:Ortiz, Stephan Pittock, Sean Berthele, Achim Levy, Michael Nakashima, Ichiro Oreja Guevara, Celia Kim, Ho Jin
Session Name:S5: Autoimmune Neurology: NMOSD and MG, A Focus on Treatment Trials
Topic:Autoimmune Neurology
Program Number:S5.004
Author Institution:Alexion, AstraZeneca Rare Disease, Boston, MA, USA, Boston, MA Department of Neurology, Center MS and Autoimmune Neurology, Mayo Clinic, Rochester, MN, USA, Rochester, MN Department of Neurology, School of Medicine, Technical University Munich, Munich, Germany, Munich, Germany Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA, Boston, MA Department of Neurology, Tohoku University Graduate School of Medicine Department of Neurology, Tohoku Medical and Pharmaceutical University, Sendai, Japan, Sendai, Japan Department of Neurology, Hospital Clínico Universitario San Carlos Department of Medicine, Universidad Complutense de Madrid, Madrid, Spain, Madrid, Spain Department of Neurology, National Cancer Center, Goyang, South Korea , Goyang, Korea, Republic of
Author:Pittock, Sean Paul, Friedemann Kim, Ho Jin Smith, Michael Rees, William Patterson, Kristina Cree, Bruce Bennett, Jeffrey
Session Name:S5: Autoimmune Neurology: NMOSD and MG, A Focus on Treatment Trials
Topic:Autoimmune Neurology
Program Number:S5.005
Author Institution:Mayo Clinic Dept of Neuro, Rochester, MN Charite Universitatsmedizin in Berlin, Berlin, Germany National Cancer Center, Goyang, Korea, Republic of Horizon Therapeutics plc, Gaithersburg, MD Horizon Therapeutics plc, Deerfield, IL UCSF, Multiple Sclerosis Center, San Francisco, CA University of Colorado School of Medicine, Aurora, CO
Displaying 1 - 5 of 10